What is Wave Life Sciences's AOCI?

Wave Life Sciences (WVE) reported AOCI of -$254K in Q1 2026.

How has Wave Life Sciences's AOCI changed year-over-year?

Wave Life Sciences's AOCI decreased by 24.5% year-over-year, from -$204K to -$254K.

What is the long-term trend for Wave Life Sciences's AOCI?

Over 5 years (2020 to 2025), Wave Life Sciences's AOCI has grown at a -8.5% compound annual growth rate (CAGR), from $389K to -$250K.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Wave Life Sciences WVE AOCI

AOCI at other companies

Eli LillyLLY

-$2.83B+24.9%

Sarepta Therapeutics, Inc.SRPT

-$121K-456%

Ionis PharmaceuticalsIONS

-$31.02M-7.2%

Madrigal Pharmaceuticals, Inc.MDGL

$1.08M+178%

ALN

Alnylam PharmaceuticalsALNY

-$24.89M+33.6%

Beam TherapeuticsBEAM

-$1.07M-769%

Other financials

Income statement

See full

Revenue$38.2M+317%

Operating income-$31.3M+37.2%

Net income-$26.1M+44.4%

EPS (diluted)-$0.13+55.2%

Balance sheet

See full

Cash & equivalents$544.6M+124%

Total debt$15.7M-33.4%

Total equity$511.7M+198%

Total assets$583.5M+102%

Cash flow

See full

Operating cash flow-$59.6M+5.5%

CapEx$438.0K+165%

Free cash flow-$60.0M+5.1%

Valuation

See full

Market cap$1.14B+13.0%

Enterprise value$615.92M-22.3%

P/S15.1×-12.2×

Profitability

See full

Operating margin-75.7%-33.6pp

Net margin-66.5%-29.9pp

FCF margin-27.2%-12.6pp

Returns & leverage

See full

Return on equity-53.7%—

Debt / equity0×-0.1×

Current ratio11.3×+8.3×

Where this comes from

Reported directly by Wave Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Wave Life Sciences's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Wave Life Sciences's AOCI?: Wave Life Sciences (WVE) reported AOCI of -$254K in Q1 2026.
How has Wave Life Sciences's AOCI changed year-over-year?: Wave Life Sciences's AOCI decreased by 24.5% year-over-year, from -$204K to -$254K.
What is the long-term trend for Wave Life Sciences's AOCI?: Over 5 years (2020 to 2025), Wave Life Sciences's AOCI has grown at a -8.5% compound annual growth rate (CAGR), from $389K to -$250K.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.